Andrew R. Allen, See Remarks at Clovis Oncology, Inc. (CLVS), sold 22,594 shares at $66.89 ($1.5M) on 2013-06-05, disclosed to the SEC on 2013-06-07.
Open-market sale of $1.5M CLVS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.77 | 700 | $46K | 3.0% |
| 2 | $66.89 | 4,500 | $301K | 19.4% |
| 3 | $67.65 | 6,494 | $439K | 28.4% |
| 4 | $68.84 | 2,500 | $172K | 11.1% |
| 5 | $70.06 | 5,800 | $406K | 26.2% |
| 6 | $70.72 | 2,600 |
| $184K |
| 11.9% |
| Total | $68.54 avg | 22,594 | $1.5M | 100% |
| Filing → |
| CLVS | SELL | 2015-01-21 | $5.3M | — | Filing → |
| CLVS | SELL | 2015-01-20 | $3.2M | — | Filing → |
| CLVS | BUY | 2011-11-21 | $50K | — | Filing → |